MCE - Delayed Quote EUR
Laboratorios Farmaceuticos Rovi, S.A. (ROVI.MC)
52.80
-0.65
(-1.22%)
At close: May 14 at 5:44:27 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 5 | 7 |
| Avg. Estimate | 0 | 0 | 2.55 | 3.29 |
| Low Estimate | 0 | 0 | 2.47 | 2.65 |
| High Estimate | 0 | 0 | 2.65 | 3.75 |
| Year Ago EPS | -- | -- | 2.67 | 2.55 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 7 | 8 |
| Avg. Estimate | -- | -- | 726.43M | 840M |
| Low Estimate | -- | -- | 707M | 790.2M |
| High Estimate | -- | -- | 751M | 921M |
| Year Ago Sales | -- | -- | 763.75M | 726.43M |
| Sales Growth (year/est) | -- | -- | -4.89% | 15.63% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 2.55 | 3.29 |
| 7 Days Ago | 0 | 0 | 2.53 | 3.29 |
| 30 Days Ago | 0 | 0 | 2.53 | 3.29 |
| 60 Days Ago | 0 | 0 | 2.62 | 3.66 |
| 90 Days Ago | 0 | 0 | 3.16 | 4.04 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 1 |
| Up Last 30 Days | -- | -- | 1 | 1 |
| Down Last 7 Days | -- | -- | 1 | 1 |
| Down Last 30 Days | -- | -- | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ROVI.MC | -- | -- | -4.70% | 29.11% |
| S&P 500 | 13.20% | 2.98% | 8.01% | 13.77% |
Related Tickers
ALM.MC Almirall, S.A.
9.99
-4.13%
RJF.MC Laboratorio Reig Jofre, S.A.
3.0100
+1.01%
FAE.MC Faes Farma, S.A.
4.1650
-0.36%
GALD.SW Galderma Group N
98.00
0.00%
1MRK.MI Merck KGaA
124.10
-1.47%
TEV.F Teva Pharmaceutical Industries Limited
15.45
-1.90%
PPGN.SW PolyPeptide Group AG
19.92
+38.14%
IPN.PA Ipsen S.A.
100.60
-1.85%
FAGR.BR Fagron NV
21.35
+0.47%
MOB.ST Moberg Pharma AB (publ)
8.14
+7.81%